|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/4184 | |||
| A61K 31/575 | |||
| A61K 39/395 | |||
| A61P 27/02 |
| (11) | Patento numeris | 2187743 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08827362.8 |
| Europos patento paraiškos padavimo data | 2008-08-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-05-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/073520 |
| Data | 2008-08-18 |
| (87) | Numeris | WO 2009/023877 |
| Data | 2009-02-19 |
| (30) | Numeris | Data | Šalis |
| 965282 P | 2007-08-16 | US | |
| 965258 P | 2007-08-16 | US |
| (72) |
DOR, Philippe, Jm, US
MUDUMBA, Sreenivasu, US
NIVAGGIOLI, Thierry, US
WEBER, David, A., US
FAROOQ, Sidiq, US
TAKHAR, Sudeep, Kaur, US
|
| (73) |
Santen Pharmaceutical Co., Ltd,
9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, Osaka 533-8651,
JP
|
| (54) | Rapamycin formulations for treatment of age related macular degeneration |
| Rapamycin formulations for treatment of age related macular degeneration |